n-Hexane (Hexane)

Where It Comes From

n-Hexane was first synthesized in the 19th century and emerged as an important industrial solvent in the 20th century [1]. Large-scale commercial production began in the early 1900s through petroleum refining. The compound became widely used as an extraction solvent in food processing (especially vegetable oil extraction), chemical manufacturing, and numerous industrial applications. n-Hexane's usefulness derived from its excellent solvent properties for non-polar compounds and its ease of recovery through evaporation. By the mid-20th century, n-hexane was one of the most widely used industrial solvents globally [2]. A major occupational health concern emerged in the 1960s-1970s when peripheral neuropathy cases were reported in workers chronically exposed to n-hexane vapor. These cases demonstrated that n-hexane causes selective neurological damage distinct from simple solvent narcosis [3].

How You Are Exposed

Industrial workers in food oil extraction face the highest occupational exposure to n-hexane vapor. Chemical manufacturing workers and laboratory personnel encounter chronic exposure during solvent use. Shoe manufacturing and glue workers experience exposure to n-hexane-containing adhesives. Inhalation of vapor is the primary occupational exposure route.

Why It Matters

n-Hexane causes peripheral neuropathy (nerve damage in extremities) at moderate-to-high occupational concentrations. The compound forms toxic metabolites (2,5-hexanedione) that specifically damage peripheral nerves, causing weakness, numbness, and dysfunction of distal limbs. Peripheral neuropathy is disabling and may be irreversible even after exposure cessation. Acute high-concentration exposure causes central nervous system effects and respiratory irritation.

Who Is at Risk

Industrial workers in food oil extraction experience the highest risk. Chemical manufacturing and laboratory workers with prolonged solvent exposure face significant risk. Workers in shoe manufacturing and glue-using industries encounter chronic exposure. Vulnerable populations include workers with pre-existing neurological disease.

Recovery & Clinical Information

Body Half-Life

n-Hexane is readily absorbed through inhalation with high pulmonary uptake of vapor. Limited skin absorption occurs. The compound undergoes hepatic metabolism to form gamma-hexane (a precursor metabolite) and 2,5-hexanedione (the primary toxic metabolite). The elimination half-life of n-hexane is approximately 1-2 hours. However, 2,5-hexanedione persists much longer (hours to days).

Testing & Biomarkers

Occupational air monitoring detects n-hexane vapor during exposure. Urinary 2,5-hexanedione (the toxic metabolite) indicates systemic absorption and is used for occupational biomonitoring. Neurological examination and electromyography (EMG) assess peripheral nerve function. Baseline and periodic neurological assessments detect early neuropathy development.

Interventions

Management of n-hexane exposure focuses on prevention of neurological damage through exposure elimination. Acute solvent exposure is managed with removal from exposure and supportive care. Chronic peripheral neuropathy management includes supportive care, pain management, physical therapy, and occupational rehabilitation. Unfortunately, established neuropathy is often irreversible.

Recovery Timeline

Acute CNS symptoms develop within minutes to hours of high-concentration exposure. Peripheral neuropathy develops insidiously over weeks to months of chronic moderate exposure. Symptoms may progress for months even after exposure cessation due to continued metabolite accumulation. Recovery may take years or be incomplete.

Recovery References

[1][1] March, J. (1992). 'Advanced Organic Chemistry.' John Wiley & Sons.
[2][2] Schaumburg, H. H., & Spencer, P. S. (1976). 'Experimental n-Hexane Neuropathy.' Journal of Neuropathology & Experimental Neurology, 35(2), 207-225.
[3][3] ATSDR (2010). 'Toxicological Profile for n-Hexane.' Agency for Toxic Substances and Disease Registry.